SE431469B - Harts, hartskombination samt forfarande for selektiv avskiljning av bakterieinhibitorer, sasom antibiotika, ur bakteriellt infekterade kroppsvetskor - Google Patents

Harts, hartskombination samt forfarande for selektiv avskiljning av bakterieinhibitorer, sasom antibiotika, ur bakteriellt infekterade kroppsvetskor

Info

Publication number: SE431469B
Authority: SE; Sweden
Prior art keywords: resin; sample; surfactant; resins; body fluid
Prior art date: 1977-12-02

Application number

SE7812264A

Other languages

English (en)

Swedish (sv)

Other versions

SE7812264L (sv

Inventor

J L Melnick

C Wallis

Original Assignee

Baylor College Medicine

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1977-12-02

Filing date

1978-11-28

Publication date

1984-02-06

1978-11-28 Application filed by Baylor College Medicine filed Critical Baylor College Medicine

1979-06-03 Publication of SE7812264L publication Critical patent/SE7812264L/xx

1984-02-06 Publication of SE431469B publication Critical patent/SE431469B/sv

Links

241000894006 Bacteria Species 0.000 title claims description 52
239000003242 anti bacterial agent Substances 0.000 title claims description 48
229940088710 antibiotic agent Drugs 0.000 title claims description 40
238000000034 method Methods 0.000 title claims description 22
239000003112 inhibitor Substances 0.000 title claims description 19
238000000926 separation method Methods 0.000 title claims description 7
235000009508 confectionery Nutrition 0.000 title 1
239000011347 resin Substances 0.000 claims description 200
229920005989 resin Polymers 0.000 claims description 200
210000004369 blood Anatomy 0.000 claims description 48
239000008280 blood Substances 0.000 claims description 48
239000004094 surface-active agent Substances 0.000 claims description 32
230000001580 bacterial effect Effects 0.000 claims description 28
210000001124 body fluid Anatomy 0.000 claims description 27
239000010839 body fluid Substances 0.000 claims description 27
230000003115 biocidal effect Effects 0.000 claims description 24
239000003463 adsorbent Substances 0.000 claims description 23
239000003729 cation exchange resin Substances 0.000 claims description 17
238000001179 sorption measurement Methods 0.000 claims description 14
NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 claims description 13
210000002700 urine Anatomy 0.000 claims description 13
239000002736 nonionic surfactant Substances 0.000 claims description 12
239000003957 anion exchange resin Substances 0.000 claims description 11
MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 claims description 10
PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 claims description 8
125000002091 cationic group Chemical group 0.000 claims description 8
239000012530 fluid Substances 0.000 claims description 8
239000011248 coating agent Substances 0.000 claims description 5
238000000576 coating method Methods 0.000 claims description 5
239000002202 Polyethylene glycol Substances 0.000 claims description 4
150000001346 alkyl aryl ethers Chemical class 0.000 claims description 4
229920001577 copolymer Polymers 0.000 claims description 4
238000002955 isolation Methods 0.000 claims description 4
229920001223 polyethylene glycol Polymers 0.000 claims description 4
238000005349 anion exchange Methods 0.000 claims 1
239000000523 sample Substances 0.000 description 51
239000000203 mixture Substances 0.000 description 24
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 18
238000012360 testing method Methods 0.000 description 14
GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 14
230000002401 inhibitory effect Effects 0.000 description 13
239000001963 growth medium Substances 0.000 description 12
125000000129 anionic group Chemical group 0.000 description 11
239000012153 distilled water Substances 0.000 description 10
239000013504 Triton X-100 Substances 0.000 description 9
229920004890 Triton X-100 Polymers 0.000 description 9
238000009640 blood culture Methods 0.000 description 9
241000588724 Escherichia coli Species 0.000 description 7
239000000463 material Substances 0.000 description 7
239000000126 substance Substances 0.000 description 7
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 6
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
230000000694 effects Effects 0.000 description 6
241000191967 Staphylococcus aureus Species 0.000 description 5
IYNDLOXRXUOGIU-LQDWTQKMSA-M benzylpenicillin potassium Chemical compound [K+].N([C@H]1[C@H]2SC([C@@H](N2C1=O)C([O-])=O)(C)C)C(=O)CC1=CC=CC=C1 IYNDLOXRXUOGIU-LQDWTQKMSA-M 0.000 description 5
229940023913 cation exchange resins Drugs 0.000 description 5
210000001175 cerebrospinal fluid Anatomy 0.000 description 5
238000011534 incubation Methods 0.000 description 5
239000002609 medium Substances 0.000 description 5
JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 4
239000000706 filtrate Substances 0.000 description 4
208000015181 infectious disease Diseases 0.000 description 4
239000003456 ion exchange resin Substances 0.000 description 4
229920003303 ion-exchange polymer Polymers 0.000 description 4
239000007788 liquid Substances 0.000 description 4
239000011148 porous material Substances 0.000 description 4
229920001817 Agar Polymers 0.000 description 3
239000008272 agar Substances 0.000 description 3
150000001450 anions Chemical class 0.000 description 3
238000009534 blood test Methods 0.000 description 3
210000000988 bone and bone Anatomy 0.000 description 3
229910002092 carbon dioxide Inorganic materials 0.000 description 3
239000001569 carbon dioxide Substances 0.000 description 3
238000012258 culturing Methods 0.000 description 3
239000003085 diluting agent Substances 0.000 description 3
230000002458 infectious effect Effects 0.000 description 3
239000002952 polymeric resin Substances 0.000 description 3
229920006395 saturated elastomer Polymers 0.000 description 3
229920003002 synthetic resin Polymers 0.000 description 3
108010078777 Colistin Proteins 0.000 description 2
ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
229930182566 Gentamicin Natural products 0.000 description 2
CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 2
RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 description 2
240000007930 Oxalis acetosella Species 0.000 description 2
235000008098 Oxalis acetosella Nutrition 0.000 description 2
229930182555 Penicillin Natural products 0.000 description 2
108010093965 Polymyxin B Proteins 0.000 description 2
239000004793 Polystyrene Substances 0.000 description 2
FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
230000002378 acidificating effect Effects 0.000 description 2
AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
230000000845 anti-microbial effect Effects 0.000 description 2
239000013060 biological fluid Substances 0.000 description 2
FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 description 2
VUFGUVLLDPOSBC-XRZFDKQNSA-M cephalothin sodium Chemical compound [Na+].N([C@H]1[C@@H]2N(C1=O)C(=C(CS2)COC(=O)C)C([O-])=O)C(=O)CC1=CC=CS1 VUFGUVLLDPOSBC-XRZFDKQNSA-M 0.000 description 2
229920001429 chelating resin Polymers 0.000 description 2
239000003795 chemical substances by application Substances 0.000 description 2
KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 description 2
238000007796 conventional method Methods 0.000 description 2
229910003460 diamond Inorganic materials 0.000 description 2
239000010432 diamond Substances 0.000 description 2
125000000524 functional group Chemical group 0.000 description 2
238000005342 ion exchange Methods 0.000 description 2
150000002500 ions Chemical class 0.000 description 2
239000007791 liquid phase Substances 0.000 description 2
229960003085 meticillin Drugs 0.000 description 2
238000002156 mixing Methods 0.000 description 2
ZESIAEVDVPWEKB-ORCFLVBFSA-N n-[(2s)-4-amino-1-[[(2s,3r)-1-[[(2s)-4-amino-1-oxo-1-[[(3s,6s,9s,12s,15r,18s,21s)-6,9,18-tris(2-aminoethyl)-3-[(1r)-1-hydroxyethyl]-12,15-bis(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-h Chemical compound OS(O)(=O)=O.OS(O)(=O)=O.CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H]([C@@H](C)O)CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O.CCC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H]([C@@H](C)O)CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O ZESIAEVDVPWEKB-ORCFLVBFSA-N 0.000 description 2
229940049954 penicillin Drugs 0.000 description 2
210000002381 plasma Anatomy 0.000 description 2
229920000136 polysorbate Polymers 0.000 description 2
229920002223 polystyrene Polymers 0.000 description 2
125000001453 quaternary ammonium group Chemical group 0.000 description 2
210000002966 serum Anatomy 0.000 description 2
229910001415 sodium ion Inorganic materials 0.000 description 2
239000002594 sorbent Substances 0.000 description 2
210000000278 spinal cord Anatomy 0.000 description 2
-1 "XAG-4" Substances 0.000 description 1
JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
ZXBDZLHAHGPXIG-VTXLJDRKSA-N (3r,4s,5s,6r,7r,9r,11r,12r,13s,14r)-6-[(2s,3r,4s,6r)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2r,4r,5s,6s)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione;(2r,3 Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O)C(O)=O.O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ZXBDZLHAHGPXIG-VTXLJDRKSA-N 0.000 description 1
ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
CZWJCQXZZJHHRH-YCRXJPFRSA-N 2-[(1r,2r,3s,4r,5r,6s)-3-(diaminomethylideneamino)-4-[(2r,3r,4r,5s)-3-[(2s,3s,4s,5r,6s)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy-4-hydroxy-4-(hydroxymethyl)-5-methyloxolan-2-yl]oxy-2,5,6-trihydroxycyclohexyl]guanidine;sulfuric acid Chemical compound OS(O)(=O)=O.OS(O)(=O)=O.OS(O)(=O)=O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](CO)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O.CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](CO)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]1O CZWJCQXZZJHHRH-YCRXJPFRSA-N 0.000 description 1
208000002177 Cataract Diseases 0.000 description 1
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
GUTLYIVDDKVIGB-OUBTZVSYSA-N Cobalt-60 Chemical compound [60Co] GUTLYIVDDKVIGB-OUBTZVSYSA-N 0.000 description 1
241001507939 Cormus domestica Species 0.000 description 1
SBKRTALNRRAOJP-BWSIXKJUSA-N N-[(2S)-4-amino-1-[[(2S,3R)-1-[[(2S)-4-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18R,21S)-6,9,18-tris(2-aminoethyl)-15-benzyl-3-[(1R)-1-hydroxyethyl]-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxobutan-2-yl]-6-methylheptanamide (6S)-N-[(2S)-4-amino-1-[[(2S,3R)-1-[[(2S)-4-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18R,21S)-6,9,18-tris(2-aminoethyl)-15-benzyl-3-[(1R)-1-hydroxyethyl]-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxobutan-2-yl]-6-methyloctanamide sulfuric acid Chemical compound OS(O)(=O)=O.CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@@H](NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](CCN)NC1=O)[C@@H](C)O.CC[C@H](C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@@H](NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](CCN)NC1=O)[C@@H](C)O SBKRTALNRRAOJP-BWSIXKJUSA-N 0.000 description 1
229920001213 Polysorbate 20 Polymers 0.000 description 1
229920001214 Polysorbate 60 Polymers 0.000 description 1
241000588769 Proteus <enterobacteria> Species 0.000 description 1
241000589516 Pseudomonas Species 0.000 description 1
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
239000004141 Sodium laurylsulphate Substances 0.000 description 1
229920002125 Sokalan® Polymers 0.000 description 1
IYFATESGLOUGBX-YVNJGZBMSA-N Sorbitan monopalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O IYFATESGLOUGBX-YVNJGZBMSA-N 0.000 description 1
HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
241000194017 Streptococcus Species 0.000 description 1
239000004098 Tetracycline Substances 0.000 description 1
238000007792 addition Methods 0.000 description 1
239000000654 additive Substances 0.000 description 1
230000000996 additive effect Effects 0.000 description 1
125000003158 alcohol group Chemical group 0.000 description 1
QGZKDVFQNNGYKY-UHFFFAOYSA-O ammonium group Chemical group [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
229960000723 ampicillin Drugs 0.000 description 1
KLOHDWPABZXLGI-YWUHCJSESA-M ampicillin sodium Polymers [Na+].C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C([O-])=O)(C)C)=CC=CC=C1 KLOHDWPABZXLGI-YWUHCJSESA-M 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
150000001449 anionic compounds Chemical class 0.000 description 1
239000003945 anionic surfactant Substances 0.000 description 1
230000000844 anti-bacterial effect Effects 0.000 description 1
230000000721 bacterilogical effect Effects 0.000 description 1
230000003385 bacteriostatic effect Effects 0.000 description 1
239000011324 bead Substances 0.000 description 1
239000012496 blank sample Substances 0.000 description 1
210000004204 blood vessel Anatomy 0.000 description 1
238000007664 blowing Methods 0.000 description 1
229960003669 carbenicillin Drugs 0.000 description 1
150000001732 carboxylic acid derivatives Chemical group 0.000 description 1
238000005341 cation exchange Methods 0.000 description 1
229960000603 cefalotin Drugs 0.000 description 1
229940063193 cleocin Drugs 0.000 description 1
229960002227 clindamycin Drugs 0.000 description 1
229960003346 colistin Drugs 0.000 description 1
239000012141 concentrate Substances 0.000 description 1
238000009833 condensation Methods 0.000 description 1
230000005494 condensation Effects 0.000 description 1
238000010276 construction Methods 0.000 description 1
239000000356 contaminant Substances 0.000 description 1
230000007423 decrease Effects 0.000 description 1
239000000645 desinfectant Substances 0.000 description 1
238000001514 detection method Methods 0.000 description 1
229960001162 dihydrostreptomycin sulfate Drugs 0.000 description 1
238000010790 dilution Methods 0.000 description 1
239000012895 dilution Substances 0.000 description 1
230000008034 disappearance Effects 0.000 description 1
239000003814 drug Substances 0.000 description 1
229940079593 drug Drugs 0.000 description 1
229960003276 erythromycin Drugs 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
229940064238 ilotycin Drugs 0.000 description 1
239000007924 injection Substances 0.000 description 1
238000002347 injection Methods 0.000 description 1
229960000318 kanamycin Drugs 0.000 description 1
229930027917 kanamycin Natural products 0.000 description 1
SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
229930182823 kanamycin A Natural products 0.000 description 1
238000002372 labelling Methods 0.000 description 1
150000002605 large molecules Chemical class 0.000 description 1
229920002521 macromolecule Polymers 0.000 description 1
238000011140 membrane chromatography Methods 0.000 description 1
230000003278 mimic effect Effects 0.000 description 1
JORAUNFTUVJTNG-BSTBCYLQSA-N n-[(2s)-4-amino-1-[[(2s,3r)-1-[[(2s)-4-amino-1-oxo-1-[[(3s,6s,9s,12s,15r,18s,21s)-6,9,18-tris(2-aminoethyl)-3-[(1r)-1-hydroxyethyl]-12,15-bis(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-h Chemical compound CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H]([C@@H](C)O)CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O.CCC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H]([C@@H](C)O)CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O JORAUNFTUVJTNG-BSTBCYLQSA-N 0.000 description 1
235000015097 nutrients Nutrition 0.000 description 1
229920002113 octoxynol Polymers 0.000 description 1
UOZODPSAJZTQNH-LSWIJEOBSA-N paromomycin Chemical compound N[C@@H]1[C@@H](O)[C@H](O)[C@H](CN)O[C@@H]1O[C@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](N)C[C@@H](N)[C@@H]2O)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)O[C@@H]1CO UOZODPSAJZTQNH-LSWIJEOBSA-N 0.000 description 1
230000001717 pathogenic effect Effects 0.000 description 1
229940056360 penicillin g Drugs 0.000 description 1
230000010399 physical interaction Effects 0.000 description 1
239000002504 physiological saline solution Substances 0.000 description 1
229920001467 poly(styrenesulfonates) Polymers 0.000 description 1
229920000642 polymer Polymers 0.000 description 1
229920000024 polymyxin B Polymers 0.000 description 1
XDJYMJULXQKGMM-UHFFFAOYSA-N polymyxin E1 Natural products CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(C(C)O)NC(=O)C(CCN)NC(=O)C(CCN)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCN)NC1=O XDJYMJULXQKGMM-UHFFFAOYSA-N 0.000 description 1
KNIWPHSUTGNZST-UHFFFAOYSA-N polymyxin E2 Natural products CC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(C(C)O)NC(=O)C(CCN)NC(=O)C(CCN)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCN)NC1=O KNIWPHSUTGNZST-UHFFFAOYSA-N 0.000 description 1
229960005266 polymyxin b Drugs 0.000 description 1
239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
229920000053 polysorbate 80 Polymers 0.000 description 1
229920005990 polystyrene resin Polymers 0.000 description 1
239000000047 product Substances 0.000 description 1
238000000746 purification Methods 0.000 description 1
230000002285 radioactive effect Effects 0.000 description 1
150000003839 salts Chemical group 0.000 description 1
230000035945 sensitivity Effects 0.000 description 1
239000010802 sludge Substances 0.000 description 1
239000002002 slurry Substances 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
235000019333 sodium laurylsulphate Nutrition 0.000 description 1
239000000243 solution Substances 0.000 description 1
229940035044 sorbitan monolaurate Drugs 0.000 description 1
239000001593 sorbitan monooleate Substances 0.000 description 1
235000011069 sorbitan monooleate Nutrition 0.000 description 1
229940035049 sorbitan monooleate Drugs 0.000 description 1
235000011071 sorbitan monopalmitate Nutrition 0.000 description 1
239000001570 sorbitan monopalmitate Substances 0.000 description 1
229940031953 sorbitan monopalmitate Drugs 0.000 description 1
239000001587 sorbitan monostearate Substances 0.000 description 1
235000011076 sorbitan monostearate Nutrition 0.000 description 1
229940035048 sorbitan monostearate Drugs 0.000 description 1
239000007921 spray Substances 0.000 description 1
229910021653 sulphate ion Inorganic materials 0.000 description 1
239000006228 supernatant Substances 0.000 description 1
239000000725 suspension Substances 0.000 description 1
125000001302 tertiary amino group Chemical group 0.000 description 1
229960002180 tetracycline Drugs 0.000 description 1
229930101283 tetracycline Natural products 0.000 description 1
235000019364 tetracycline Nutrition 0.000 description 1
150000003522 tetracyclines Chemical class 0.000 description 1
238000002560 therapeutic procedure Methods 0.000 description 1
238000012546 transfer Methods 0.000 description 1
230000000472 traumatic effect Effects 0.000 description 1
229960005486 vaccine Drugs 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/22—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material
- B01J20/26—Synthetic macromolecular compounds
- B01J20/261—Synthetic macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/22—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material
- B01J20/26—Synthetic macromolecular compounds
- B01J20/262—Synthetic macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. obtained by polycondensation
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/22—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material
- B01J20/26—Synthetic macromolecular compounds
- B01J20/264—Synthetic macromolecular compounds derived from different types of monomers, e.g. linear or branched copolymers, block copolymers, graft copolymers
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/28—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties
- B01J20/28002—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties characterised by their physical properties
- B01J20/28004—Sorbent size or size distribution, e.g. particle size
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/28—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties
- B01J20/28054—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties characterised by their surface properties or porosity
- B01J20/28078—Pore diameter
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/3092—Packing of a container, e.g. packing a cartridge or column
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3202—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the carrier, support or substrate used for impregnation or coating
- B01J20/3206—Organic carriers, supports or substrates
- B01J20/3208—Polymeric carriers, supports or substrates
- B01J20/321—Polymeric carriers, supports or substrates consisting of a polymer obtained by reactions involving only carbon to carbon unsaturated bonds
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3231—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
- B01J20/3242—Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group
- B01J20/3268—Macromolecular compounds
- B01J20/3272—Polymers obtained by reactions otherwise than involving only carbon to carbon unsaturated bonds
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J47/00—Ion-exchange processes in general; Apparatus therefor
- B01J47/014—Ion-exchange processes in general; Apparatus therefor in which the adsorbent properties of the ion-exchanger are involved, e.g. recovery of proteins or other high-molecular compounds
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J47/00—Ion-exchange processes in general; Apparatus therefor
- B01J47/016—Modification or after-treatment of ion-exchangers
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
- G01N33/521—Single-layer analytical elements
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2220/00—Aspects relating to sorbent materials
- B01J2220/50—Aspects relating to the use of sorbent or filter aid materials
- B01J2220/58—Use in a single column
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/07—Microporous membranes

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Analytical Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Hematology (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Physics & Mathematics (AREA)
Microbiology (AREA)
Urology & Nephrology (AREA)
General Health & Medical Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biomedical Technology (AREA)
Cell Biology (AREA)
Pathology (AREA)
Biophysics (AREA)
General Physics & Mathematics (AREA)
Medicinal Chemistry (AREA)
Food Science & Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
General Engineering & Computer Science (AREA)
Genetics & Genomics (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Investigating Or Analysing Biological Materials (AREA)
Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Treatment Of Liquids With Adsorbents In General (AREA)

SE7812264A 1977-12-02 1978-11-28 Harts, hartskombination samt forfarande for selektiv avskiljning av bakterieinhibitorer, sasom antibiotika, ur bakteriellt infekterade kroppsvetskor SE431469B (sv)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US05/856,851 US4145304A (en)	1977-12-02	1977-12-02	Resin and method for removing antimicrobials from body fluids

Publications (2)

Publication Number	Publication Date
SE7812264L SE7812264L (sv)	1979-06-03
SE431469B true SE431469B (sv)	1984-02-06

Family

ID=25324644

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SE7812264A SE431469B (sv)	1977-12-02	1978-11-28	Harts, hartskombination samt forfarande for selektiv avskiljning av bakterieinhibitorer, sasom antibiotika, ur bakteriellt infekterade kroppsvetskor

Country Status (10)

Country	Link
US (1)	US4145304A (fr)
JP (1)	JPS598176B2 (fr)
BE (1)	BE885951Q (fr)
BR (1)	BR7807940A (fr)
CA (1)	CA1108515A (fr)
DE (1)	DE2852118C2 (fr)
FR (1)	FR2410470A1 (fr)
GB (1)	GB2009623B (fr)
IT (1)	IT1106436B (fr)
SE (1)	SE431469B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4460577A (en) *	1977-09-30	1984-07-17	Farmitalia Carlo Erba S.P.A.	Pharmaceutical compositions consisting or consisting essentially of liposomes, and processes for making same
AU550159B2 (en) *	1981-08-20	1986-03-06	Becton Dickinson & Company	Isolation of antimicrobial material using resin
DE3138107A1 (de) *	1981-09-24	1983-04-07	Dr. Eduard Fresenius, Chemisch-pharmazeutische Industrie KG, 6380 Bad Homburg	Verfahren zur entfernung von stoffen aus waessrigen loesungen sowie vorrichtung zur durchfuehrung des verfahrens
JPS5863382A (ja) *	1981-10-13	1983-04-15	Terumo Corp	多層微生物培養検査器
US4661344A (en) *	1982-06-01	1987-04-28	The Dow Chemical Company	Antimicrobial cation exchange composition
US5070014A (en) *	1982-09-30	1991-12-03	Wadley Technologies, Inc.	Stabilization of specimens for microbial analysis
JPS59102436A (ja) *	1982-12-02	1984-06-13	Kanegafuchi Chem Ind Co Ltd	吸着体
HU188425B (en) *	1983-02-11	1986-04-28	Richter Gedeon Vegyeszeti Gyar Rt,Hu	Process for the treatment of fermantation liquors containing vitamine b down 12 and other corrinoids and for preparing vitamine b down 12 concentrates
US4761370A (en) *	1986-06-16	1988-08-02	Cleveland Clinic Foundation	Method for determining the presence of bacteria in body fluid specimens containing bacterial inhibitors
US5162229A (en) *	1988-03-15	1992-11-10	Akzo N.V.	Device and method for enhanced recovery and detection of microbial growth in the presence of antimicrobial substances
EP0542686A1 (fr) *	1991-11-13	1993-05-19	Ciba-Geigy Ag	Méthode et récipient pour la stérilisation et la désinfection
US6057161A (en) *	1997-10-27	2000-05-02	Varian, Inc.	Method for determination of drugs of abuse in biological samples
CN102656275A (zh)	2009-07-01	2012-09-05	生物梅里埃有限公司	用于中和培养基中的抗生素的方法
ITVR20120229A1 (it)	2012-11-15	2014-05-16	Bbs Srl	Dispositivo pronto all'uso e metodo per la rimozione di interferenti da campioni da sottoporre ad esame microbiologico
ES2716568T3 (es) *	2013-03-11	2019-06-13	Becton Dickinson Co	Cartucho de detección bacteriana
JP5975000B2 (ja) *	2013-08-30	2016-08-23	株式会社ツムラ	微生物検出方法
EP2926794B1 (fr)	2014-03-17	2017-09-06	AL.CHI.MI.A. S.r.l.	Dispositif prêt à l'emploi et procédé pour éliminer les facteurs d'interférence d'échantillons à soumettre à un examen microbiologique
CN106076282B (zh) *	2016-06-07	2018-05-11	湖南大学	一种用于吸附和/或中和抗生素的树脂组合物及其应用
CN107445242B (zh) *	2017-09-13	2020-08-14	大连理工大学	一种在海水条件下同步固定多种抗生素的吸附膜

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2689227A (en) *	1952-04-25	1954-09-14	Rohm & Haas	Penicillin salts of anion exchange resins
US2987441A (en) *	1958-11-14	1961-06-06	Horner Frank W Ltd	Debittering anion-exchange resin particle surfaces of penicillin anions, and tasteless resin particles of penicillin
NL6803739A (fr) *	1968-03-15	1969-09-17
US3568846A (en) *	1968-04-29	1971-03-09	Ethyl Corp	Plastic filter media
US3856471A (en) *	1968-08-05	1974-12-24	Nasa	Amino acid analysis
US3620681A (en) *	1969-10-06	1971-11-16	Eric S Wright	Apparatus for extraction of drugs and toxic substances from blood, serum and other liquid
US3625652A (en) *	1970-03-17	1971-12-07	Marquette School Of Medicine I	Analysis of narcotics and amphetamines
US3794584A (en) *	1970-04-09	1974-02-26	Rohm & Haas	Removal of poisons and drugs from blood
GB1366203A (en) *	1971-06-29	1974-09-11	Bayer Ag	Filtration material for use in pre-coat filtration
US3753655A (en) *	1971-11-09	1973-08-21	B Schreiber	Process for isolation and separation of thyroid hormones

0
- BE BE0/202655A patent/BE885951Q/fr not_active IP Right Cessation
1977
- 1977-12-02 US US05/856,851 patent/US4145304A/en not_active Expired - Lifetime
1978
- 1978-11-23 FR FR7833045A patent/FR2410470A1/fr active Granted
- 1978-11-24 CA CA316,863A patent/CA1108515A/fr not_active Expired
- 1978-11-28 SE SE7812264A patent/SE431469B/sv not_active IP Right Cessation
- 1978-12-01 DE DE2852118A patent/DE2852118C2/de not_active Expired
- 1978-12-01 JP JP53148960A patent/JPS598176B2/ja not_active Expired
- 1978-12-01 BR BR7807940A patent/BR7807940A/pt unknown
- 1978-12-01 IT IT52157/78A patent/IT1106436B/it active
- 1978-12-04 GB GB7847089A patent/GB2009623B/en not_active Expired

Also Published As

Publication number	Publication date
JPS5493689A (en)	1979-07-24
BR7807940A (pt)	1979-07-31
IT7852157A0 (it)	1978-12-01
JPS598176B2 (ja)	1984-02-23
IT1106436B (it)	1985-11-11
DE2852118A1 (de)	1979-06-07
CA1108515A (fr)	1981-09-08
BE885951Q (fr)	1981-02-16
DE2852118C2 (de)	1983-07-28
GB2009623A (en)	1979-06-20
SE7812264L (sv)	1979-06-03
FR2410470B1 (fr)	1983-11-18
FR2410470A1 (fr)	1979-06-29
US4145304A (en)	1979-03-20
GB2009623B (en)	1982-04-07

Legal Events

Date

Code

Title

Description

1995-01-31

NUG

Patent has lapsed

Ref document number: 7812264-5

Effective date: 19900706

Format of ref document f/p: F

Publication	Publication Date	Title
SE431469B (sv)	1984-02-06	Harts, hartskombination samt forfarande for selektiv avskiljning av bakterieinhibitorer, sasom antibiotika, ur bakteriellt infekterade kroppsvetskor
KR100213841B1 (ko)	1999-08-02	항균성 물질의 존재하에서 미생물 증식을 검출 및 회수하는 개선된 장치 및 방법
Ferris et al.	1991	Method for isolation and purification of cyanobacteria
US4174277A (en)	1979-11-13	Resin and method for removing antimicrobials from body fluids
EP0597542B1 (fr)	1997-09-10	Compositions adsorbentes et méthodes de fabrication
EP3348634B1 (fr)	2023-08-09	Procédé de séparation d'acide nucléique contenu dans un échantillon comprenant un acide nucléique, et dispositif associé
US4632902A (en)	1986-12-30	Method for detecting biological activity in a body fluid
CN114807058B (zh)	2023-04-25	一种金黄色葡萄球菌噬菌体SapYZUalpha及其应用
US5624814A (en)	1997-04-29	Culture medium and method for culturing body fluids containing antibiotics
Doern et al.	1983	Detection of bacteremia in patients receiving antimicrobial therapy: an evaluation of the antimicrobial removal device and 16B medium
US20090123960A1 (en)	2009-05-14	Method for Removing Antibiotics From Blood Culture Samples
Lindsey et al.	1981	In vitro antibiotic removal and bacterial recovery from blood with an antibiotic removal device
CN106076282B (zh)	2018-05-11	一种用于吸附和/或中和抗生素的树脂组合物及其应用
Nishino	1975	An electron microscopic study of antagonism between cephalexin and erythromycin in Staphylococcus aureus
JP6049812B2 (ja)	2016-12-21	培養培地中の抗生物質の中和方法
HK23488A (en)	1988-04-08	Culture medium and method for culturing body fluids containing antimicrobials
RU2078809C1 (ru)	1997-05-10	Способ выделения гемокультуры
Breeze	1986	An antimicrobial removal device as an alternative to membrane filtration in the sterility testing of antibiotics
Towse	2005	Antimicrobial activity of marine Vibrio sp., isolate NI-22
Stevens et al.	1998	Production, extraction, and qualitative testing of penicillin: a biochemistry experiment for health science chemistry courses
Kühnen et al.	1988	Clinical evaluation of diagnostic hemoperfusion for in vivo enrichment of bacteria and fungi in comparison with a conventional blood culture technique
Lundholm	1986	Evaluation of an antimicrobial removal device (ARD®) for detection of septicemia
HK1017014A (en)	1999-11-12	Method and apparatus for testing paraffinophilic microorganisms for antimicrobial agent sensitivity
RU93001213A (ru)	1996-10-27	Способ выделения гемокультуры и питательная среда для ее роста
JP2003319773A (ja)	2003-11-11	等浸透圧性パイロジェンフリー溶液